BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/19/2026 6:52:01 AM | Browse: 1 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 124725
Country China
Received
2026-06-23 07:14
Peer-Review Started
2026-06-23 07:14
First Decision by Editorial Office Director
Return for Revision
2026-07-22 03:00
Revised
2026-07-29 12:55
Publication Fee Transferred
2026-08-07 09:34
Editorial Processing by Scientific Editor
2026-09-18 02:48
Final Academic Decision by Editor-in-Chief
Publication Technical Verification by Editorial Office Director
2026-09-18 10:34
Articles in Press
2026-09-18 10:34
Edit the Manuscript by Language Editor
2026-09-26 19:08
Typeset the Manuscript
2026-11-08 15:38
Publish the Manuscript Online
2026-11-19 06:52
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Basic Study
Article Title Weiwikang Formula ameliorates precancerous lesions of gastric cancer: Associations with the HIF-1α/BNIP3 axis, mitophagy, and glycolysis
Manuscript Source Unsolicited Manuscript
All Author List Xin-Fang Zhang, Guan-Hua Lv, Cheng-Hui Zhu, Shu-Jian An and Xi-Ran Yang
ORCID
Author(s) ORCID Number
Guan-Hua Lv http://orcid.org/0009-0002-9752-6705
Funding Agency and Grant Number
Funding Agency Grant Number
the Joint Program of the Science and Technology Plan of Liaoning Province (Natural Science Foundation - General Program) No. 2024012225-JH4/4800
Corresponding Author Guan-Hua Lv, Director, Full Professor, PhD, Department of Gastroenterology and Hepatology, Second Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Liaoning Provincial Institute of Traditional Chinese Medicine, No. 60 Huanghebei Street, Huanggu District, Shenyang 110031, Liaoning Province, China. 809007025@qq.com
Key Words Precancerous lesions of gastric cancer; Weiwikang Formula; Hypoxia-inducible factor 1-alpha/B-cell lymphoma 2/adenovirus E1B 19 kDa interacting protein 3 signaling pathway; Mitophagy; Glycolysis
Core Tip Precancerous lesions of gastric cancer are a pivotal stage in gastric carcinogenesis. In a rat model, Weiwikang Formula ameliorated gastric mucosal injury, intestinal metaplasia, dysplasia, inflammation, and oxidative stress. These effects were accompanied by coordinated changes in hypoxia-inducible factor 1-alpha, B-cell lymphoma 2/adenovirus E1B 19 kDa interacting protein 3, and molecular markers of mitophagy, oxidative phosphorylation, and glycolysis. The findings highlight a potentially relevant molecular network involving hypoxia-inducible factor 1-alpha/B-cell lymphoma 2/adenovirus E1B 19 kDa interacting protein 3 signaling, mitochondrial quality control, and metabolic remodeling, supporting further investigation of Weiwikang Formula as an intervention for precancerous lesions of gastric cancer.
Publish Date 2026-11-19 06:52
Citation

Zhang XF, Lv GH, Zhu CH, An SJ, Yang XR. Weiwikang Formula ameliorates precancerous lesions of gastric cancer: Associations with the HIF-1α/BNIP3 axis, mitophagy, and glycolysis. World J Gastrointest Oncol 2026; 18(12): 124725

URL https://www.wjgnet.com/1948-5204/full/v18/i12/124725.htm
DOI https://doi.org/10.4251/wjgo.124725
Full Article (PDF) WJGO-18-124725-with-cover.pdf